Indira Kottaiyl

Webinar: Driving Measurable Productivity Gains in CHO Cell Culture Developers are under increasing pressure to improve productivity and accelerate process development — all while building on established media platforms and workflows. Join Thermo Fisher Scientific experts and they explore how targeted media supplementation can enhance CHO cell culture performance, accelerate upstream process development, and drive measurable productivity gains without disrupting established workflows.

Regulators are shifting the biosimilar approval paradigm — prioritizing deep process understanding over large clinical trials. In this evolving landscape, defining and controlling CPPs is essential to demonstrating high similarity. Join Bioprocess Online’s Jon O’Connell on March 24th at 11 am Eastern for a live Q&A with Sarfaraz Niazi, Ph.D., Vince Narbut, and Diana Colleluori, Ph.D., as they explore how QbD and CQA insight can streamline development and regulatory success.

The ability to precisely control the activity of NMDA receptors could play a role in the treatment of a range of neurodevelopmental disorders. We caught up with GRIN Therapeutics' chief medical officer to discuss drug development. Identify Lead Solid Form Early To Reduce Timelines And Downstream Costs Devoting early-phase resources for solid form understanding and screening during a drug’s development lifecycle is critical, as doing so can help save time and resources on the path to market.